CASP1 and Alzheimer disease: At the same time, pathological innate immune activation and subsequent production of inflammatory mediators, such as NLRP3 (NOD-, LRR- and pyrin domain-containing protein 3), ASC (apoptosis-associated speck-like protein), and caspase-1, promote the progress of AD and provide an effective therapeutic target for treating AD [21].